-
Spero Therapeutics' (SPRO) Overweight Rating Reaffirmed at Cantor Fitzgerald
Источник: Buzz FX / 15 ноя 2024 10:21:18 America/Chicago
Spero Therapeutics' (SPRO) Overweight Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat November 15, 2024 Share Link copied to clipboard. Spero Therapeutics ( NASDAQ:SPRO - Get Free Report ) 's stock had its "overweight" rating r
Read more...